PMcardio key facts
- Developer of a healthcare platform designed to support doctors with diagnosis and personalized treatment of cardiovascular diseases.
- It has raised $35.9M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include Google for Startups, MedTech Innovator, Life Extension Ventures, Arieli Group, bpd partners — 14 tracked in total.
- Status: Privately Held (backing).
Who backs PMcardio
14+- ·The complete investor list: 14 names
- ·Watch PMcardio: the Monday email on marks, rounds and moves
PMcardio funding rounds
No funding rounds for PMcardio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
PMcardio investors
14 investors are on record for PMcardio, including Google for Startups, MedTech Innovator, Life Extension Ventures and Arieli Group.
About PMcardio
Developer of a healthcare platform designed to support doctors with diagnosis and personalized treatment of cardiovascular diseases. The company's platform offers diagnosis reports, data collection, and personalized treatment plans using the integration of artificial intelligence and machine learning-based algorithms, enabling the medical industry to tackle challenges related to modern medicine and diagnostics.
- Sector
- Healthcare
- HQ
- Bratislava, Slovakia
- Founded
- 2017
- Employees
- 52
- Website
- powerfulmedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
PMcardio doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.